Global In-vitro Fertilization (IVF) Devices Market 2015-2019
About IVF Devices
Globally one in six couples face infertility issues. IVF is one of the popular treatments that has benefitted childless couples, single mothers, and LGBT community. It involves specific and complicated procedures with mixed proportion of both success and failure. According to CDC, nearly 1.5 million cycles of IVF is performed worldwide every year, and about 55 percent of the reported cycles are carried out in Europe. The Global IVF Devices market is growing at high pace, promising high return on investment.
TechNavio's analysts forecast the Global IVF Devices market to grow at a CAGR of 10.80 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global IVF Devices market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the following IVF devices based on the type of products, namely:
TechNavio Announces the Publication of its Research Report – Global IVF Devices Market 2015-2019
TechNavio recognizes the following companies as the key players in the Global IVF Devices Market: Cook Medical Inc., CooperSurgical Inc., Irvine Scientific Sales Co. Inc. and Vitrolife AB
Other Prominent Vendors in the market are: Auxogyn, Cell Cura, EMD Serono, Fertility Focus, IKS International, In Vitro Care, INVO Bioscience, IVFtech Aps, Kitazato, Life Global, Meditex, Microtech IVF, Nidacon International, NuSep, Ovascience, Pantec Biosolutions, Reproductive Health Science, ReproTech, Smiths Medical International, Sperm Processor and Xytex Cryo International
Commenting on the report, an analyst from TechNavio’s team said: “One key trend upcoming in this market is the increase in medical tourism. Many couples from developed countries travel to developing countries such as India and Thailand for cheaper IVF treatments.”
According to the report, increased adoption of IVF treatment and its enhanced success rates are the major contributors to the growth of the market. While other ART procedures offer success rates of about 33 percent for patients below 35 years, the average rate of success for IVF is about 40 percent. The increase in technological innovation in assisted reproduction enables couples to select embryos of their choice and have an offspring with the closest genetic resemblance to them.
Further, the report states that the market is hampered by challenges such as the high costs associated with IVF procedures and restrictive regulations in many countries. The cost of the procedure depends on the number of cycles required. Moreover, alternative procedures such as ZIFT and GIFT are cheaper than IVF.
Cook Medical , Cooper Surgical , Irvine Scientific Sales, Vitrolife , Auxogyn, Cell Cura, EMD Serono, Fertility Focus, IKS International , In Vitro Care, INVO Bioscience, IVFtech Aps, Kitazato , Life Global, Meditex, Microtech IVF s.r.o, Nidacon International, NuSep, Ovascience , Pantec Biosolutions, Reproductive Health Science , ReproTech , Smiths Medicals International , Sperm Processor , Xytexcryp International
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook